Display options
Share it on

PeerJ. 2020 Aug 21;8:e9788. doi: 10.7717/peerj.9788. eCollection 2020.

Human granulocyte-colony stimulating factor (G-CSF)/stem cell factor (SCF) fusion proteins: design, characterization and activity.

PeerJ

Gitana Mickiene, Indrė Dalgėdienė, Gintautas Zvirblis, Zilvinas Dapkunas, Ieva Plikusiene, Ernesta Buzavaite-Verteliene, Zigmas Balevičius, Audronė Rukšėnaitė, Milda Pleckaityte

Affiliations

  1. Institute of Biotechnology, Vilnius University, Vilnius, Lithuania.
  2. Profarma UAB, Vilnius, Lithuania.
  3. Department of Physical Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Vilnius, Lithuania.
  4. Plasmonics and Nanophotonics Laboratory, Department of Laser Technology, Center for Physical Sciences and Technology, Vilnius, Lithuania.

PMID: 32884863 PMCID: PMC7444511 DOI: 10.7717/peerj.9788

Abstract

BACKGROUND: Stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF) are well-characterized vital hematopoietic growth factors that regulate hematopoiesis. G-CSF and SCF synergistically exhibit a stimulatory effect on hematopoietic progenitors. The combination of G-CSF and SCF has been used for mobilization of peripheral blood progenitor cells in cancer and non-cancerous conditions. To overcome challenges connected with the administration of two cytokines, we developed two fusion proteins composed of human SCF and human G-CSF interspaced by an alpha-helix-forming peptide linker.

METHODS: The recombinant proteins SCF-Lα-GCSF and GCSF-Lα-SCF were purified in three steps using an ion-exchange and mixed-mode chromatography. The purity and quantity of the proteins after each stage of purification was assessed using RP-HPLC, SDS-PAGE, and the Bradford assays. Purified proteins were identified using high-performance liquid chromatography/electrospray ionization mass spectrometry (HPLC/ESI-MS) and the Western blot analyses. The molecular weight was determined by size exclusion HPLC (SE-HPLC). The activity of heterodimers was assessed using cell proliferation assays in vitro. The capacity of recombinant fusion proteins to stimulate the increase of the absolute neutrophil count in rats was determined in vivo. The binding kinetics of the proteins to immobilized G-CSF and SCF receptors was measured using total internal reflection ellipsometry and evaluated by a standard Langmuir kinetics model.

RESULTS: The novel SCF-Lα-GCSF and GCSF-Lα-SCF proteins were synthesized in

© 2020 Mickiene et al.

Keywords: Absolute neutrophil count; Activity; Cytokines; Fusion proteins; G-CSF; Hematopoiesis; Linker; Protein purification; SCF

Conflict of interest statement

Gitana Mickiene and Zilvinas Dapkunas are employes of UAB Profarma, Vilnius.

References

  1. Blood. 1994 Sep 15;84(6):1737-46 - PubMed
  2. Cell. 1991 Mar 8;64(5):1025-35 - PubMed
  3. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  4. J Hematother Stem Cell Res. 2003 Oct;12(5):491-7 - PubMed
  5. Bone Marrow Transplant. 2001 Aug;28(3):259-64 - PubMed
  6. Curr Pharm Des. 2004;10(11):1235-44 - PubMed
  7. Curr Opin Biotechnol. 2011 Dec;22(6):868-76 - PubMed
  8. Eur J Pharmacol. 2006 Mar 8;533(1-3):327-40 - PubMed
  9. ChemMedChem. 2016 Nov 21;11(22):2474-2495 - PubMed
  10. Blood. 1997 Nov 15;90(10):3874-83 - PubMed
  11. EMBO Mol Med. 2012 Oct;4(10):1015-28 - PubMed
  12. Acta Haematol. 1996;95(3-4):257-62 - PubMed
  13. Clin Cancer Res. 1997 Sep;3(9):1571-8 - PubMed
  14. Oncology. 1994 Mar-Apr;51(2):205-14 - PubMed
  15. Front Biosci. 2006 Sep 01;11:3181-9 - PubMed
  16. Pediatr Nephrol. 2015 Nov;30(11):2029-36 - PubMed
  17. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  18. Protein Expr Purif. 2005 Jun;41(2):402-8 - PubMed
  19. EMBO J. 2000 Jul 3;19(13):3192-203 - PubMed
  20. Cell. 1990 Oct 5;63(1):225-33 - PubMed
  21. Exp Hematol. 1991 Mar;19(3):226-31 - PubMed
  22. Blood. 1997 Aug 15;90(4):1345-64 - PubMed
  23. Mol Biotechnol. 2017 Oct;59(9-10):374-384 - PubMed
  24. Leukemia. 1997 May;11(5):701-8 - PubMed
  25. Biochem J. 1995 Jan 15;305 ( Pt 2):563-8 - PubMed
  26. Lancet. 1992 Mar 14;339(8794):640-4 - PubMed
  27. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Mar 25;786(1-2):17-32 - PubMed
  28. Cell Tissue Res. 2016 Dec;366(3):523-531 - PubMed
  29. J Immunol. 2015 Aug 15;195(4):1341-9 - PubMed
  30. Drug Discov Today. 2014 Oct;19(10):1623-31 - PubMed
  31. Am J Hematol. 2014 Mar;89(3):243-8 - PubMed
  32. Blood. 1997 May 1;89(9):3136-47 - PubMed
  33. J Biol Chem. 1991 Oct 5;266(28):18942-8 - PubMed
  34. Adv Drug Deliv Rev. 2013 Oct;65(10):1357-69 - PubMed
  35. J Immunotoxicol. 2007 Jan;4(1):69-76 - PubMed
  36. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4671-4 - PubMed
  37. Bone Marrow Transplant. 2011 Jul;46(7):936-42 - PubMed
  38. Biol Pharm Bull. 2014;37(3):335-9 - PubMed
  39. J Biol Chem. 1996 May 10;271(19):11309-16 - PubMed
  40. Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3135-40 - PubMed
  41. Lancet. 1988 Mar 26;1(8587):667-72 - PubMed
  42. Stem Cells Transl Med. 2015 Jan;4(1):66-73 - PubMed
  43. Blood. 2004 Sep 1;104(5):1306-13 - PubMed
  44. Proc Soc Exp Biol Med. 1976 Jul;152(3):398-402 - PubMed
  45. Blood. 1991 Dec 1;78(11):2791-808 - PubMed
  46. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7732-7 - PubMed
  47. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5010-4 - PubMed
  48. BioDrugs. 2015 Aug;29(4):215-39 - PubMed
  49. Annu Rev Pathol. 2016 May 23;11:555-81 - PubMed
  50. Biochemistry. 1996 Apr 16;35(15):4886-96 - PubMed
  51. J Biol Chem. 2004 Oct 22;279(43):44544-53 - PubMed
  52. Cell. 2017 Mar 9;168(6):1041-1052.e18 - PubMed
  53. Nat Rev Dis Primers. 2017 Jun 08;3:17032 - PubMed
  54. J Biol Chem. 1997 Mar 7;272(10):6406-15 - PubMed
  55. Biotechnol Lett. 2003 Feb;25(3):205-11 - PubMed
  56. Protein Eng. 2001 Aug;14(8):529-32 - PubMed
  57. Blood. 1989 Nov 15;74(7):2343-8 - PubMed
  58. Toxicol Pathol. 1999 Jan-Feb;27(1):72-7 - PubMed
  59. Cell. 1990 Oct 5;63(1):195-201 - PubMed

Publication Types